Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing

Last updated: September 25, 2021
Sponsor: University of Maryland, Baltimore
Overall Status: Terminated

Phase

4

Condition

Chest Pain

Congestive Heart Failure

Heart Failure

Treatment

N/A

Clinical Study ID

NCT03746002
HP-00082982
  • Ages 18-89
  • All Genders

Study Summary

The purpose of this study is to examine whether administering metolazone 60 minutes prior to furosemide increases urine output compared with administering metolazone and furosemide concomitantly. Participants will have equal chance of being assigned to each group.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Admission within 48 hours for acute decompensated heart failure with at least onesymptom and one sign of volume overload
  • Receipt of loop diuretic prior to admission
  • Plan to administer furosemide 120 - 160 mg IV bolus twice daily over the next 24 hourswith additional diuresis deemed necessary
  • If patient is concurrently administered intravenous vasodilator or inotrope, the doseof vasodilator or inotrope must be stable for 6 hours prior to enrollment with a planto continue the same dose for the 24 hour duration of this study

Exclusion

Exclusion Criteria:

  • Metolazone prescribed prior to admission
  • Receipt of continuous intravenous infusion of furosemide
  • Cirrhosis or end stage renal disease
  • Non-English speaking patients

Study Design

Total Participants: 3
Study Start date:
January 01, 2019
Estimated Completion Date:
January 10, 2020

Study Description

Diuretic resistance is common among patients with acute decompensated heart failure, and one strategy for overcoming this phenomenon is sequential nephron blockade with loop plus thiazide-type diuretics. Metolazone is an oral thiazide-type diuretic commonly used for this purpose. Due to its delayed absorption, some clinicians suggest that metolazone be given 30-60 minutes prior to the loop diuretic. However, the efficacy and safety of such a strategy has not been investigated despite its added complexity. The purpose of this study is to investigate whether pre-dosing with metolazone confers a difference in efficacy and safety compared to administering it at the same time as furosemide.

Connect with a study center

  • University of Maryland Medical Center

    Baltimore, Maryland 21201
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.